InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by BAUM CHARLES M, Chairman & CEO. Insider active across 2 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 11 filings have been recorded. Total volume traded: €1.1m. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
039,300 shares0
Common Stock
SEC:0001209191-22-037669:0·
025,543 shares0
Common Stock
SEC:0001214659-22-000856·
025,543 shares0
Common Stock
SEC:0001214659-22-000856:0·
€528,7164,045 shares@ €130.708522.6% of flow
Common Stock
SEC:0001214659-22-000419:0·
€528,7164,045 shares@ €130.708545.3% of flow
Common Stock
SEC:0001214659-22-000419·
07,430 shares0
Common Stock
SEC:0001214659-21-013378·
07,430 shares0
Common Stock
SEC:0001214659-21-013378:0·
€354,46247,204 shares@ €7.509230.3% of flow
Common Stock
SEC:0001214659-21-012712·
€354,46247,204 shares@ €7.509215.2% of flow
Common Stock
SEC:0001214659-21-012712:0·
€285,05740,000 shares@ €7.126424.4% of flow
Common Stock
SEC:0001214659-21-006762·
€285,05740,000 shares@ €7.126412.2% of flow
Common Stock
SEC:0001214659-21-006762:0·
11 of 11 declarations
About BAUM CHARLES M
Charles M. Baum is the President, CEO, and Board Member at Mirati Therapeutics, Inc. and Poseida Therapeutics, Inc. He leads these companies with an innovation-focused vision in the biopharmaceutical sector. His leadership is essential for achieving strategic objectives and strengthening the market position of these firms.
